Influence of
a Transjugular Intrahepatic Portosystemic Shunt on Insulin Resistance
Štefánková J.1, Šafka V.2, Fejfar T.1, Hůlek P.1, Dresslerová I.1, Krajina A.3
1I. interní klinika Lékařské fakulty UK a FN, Hradec Králové, přednosta doc. MUDr. M. Pleskot, CSc. 2Ústav fyziologie Lékařské fakulty UK, Hradec Králové, přednosta doc. MUDr. Z. Červinková, CSc. 3Radiologická klinika Lékařské fakulty UK a FN, Hradec Králové, přednosta doc. MUDr. P. Eliáš, CSc. |
|
Summary:
Patients with cirrhosis of the liver suffer from hyperinsulinaemia and a certain degree of insulin
resistance. More frequently than in the rest of the population they have diabetes. Transjugular
intrahepatic portosystemic shunts (TIPS) as a therapeutic method in complications of portal hypertension
lead to rapid haemodynamic changes in the liver. The objective of the submitted work
was to assess whether TIPS has an impact on insulinaemia and whether it influences insulin
resistance in patients with cirrhosis of the liver. Group and methods: The authors evaluated
a group of 22 patients with cirrhosis of the liver (10 diabetics and 12 subjects without diabetes)
indicated for TIPS. They investigated the insulin and C-peptide concentration in blood obtained
by catheterization from the hepatic and portal vein before and after TIPS and in the peripheral
blood before TIPS, 1 hour, 1 day, 1 week and 1 month after TIPS. The insulin resistance was
examined by the method of the hyperinsulin euglycaemic clamp (HEC) before TIPS, 1 day, 1 week,
and 1 month after TIPS. The levels of C-peptide and insulin were assessed by the IRMA method.
The blood sugar level in HEC was measured by means of a Hemocue apparatus. The results were
evaluated by the non-parametric Wilcoxon test for two dependent samples. Results: Both groups
(diabetics and non-diabetics) were comparable as to age, sex, etiology of liver cirrhosis and
indication for TIPS. After introduction of TIPS a change of insulin clearance occurred (p = 0.01)
and a change of the insulin level in the hepatic vein immediately after TIPS (p = 0.02). Insulin
clearance before TIPS was 37 - 90 % (median 54 %) and after TIPS it declined to 0 - 79 % (median
38 %) (p = 0.01). Already 1 hour after the operation the authors observed a rise of the insulin level
in peripheral blood as compared with baseline values (p = 0.002). Statistically significant hyperinsulinaemia
persisted one month after TIPS (p = 0.005). Values of C-peptide did not change significantly
in time, neither in the hepatic vein nor in the peripheral blood. On examination of IR no
statistically significant changes occurred after TIPS. On evaluation of different groups of diabetics
and non-diabetics the IR was more marked in patients with DM (mean M = 1.7 mg/kg/min.)
than in patients without DM (3.7 mg/kg/min.) (p = 0.03). The authors did not record significant changes of IR in time in different groups. Compensation of DM was not influenced by TIPS. The
fasting blood sugar levels before TIPS and 1 month after TIPS were comparable. Conclusion: After
TIPS a rise of the insulin level in peripheral blood occurred due to the reduced insulin clearance
in the liver. Despite hyperinsulinaemia which persisted for one month after the operation, the
insulin resistance did not deteriorate. Compensation of diabetes was not affected by TIPS.
Key words:
TIPS - Transjugular intrahepatic portosystemic shunt - Insulinaemia - Insulin resistance
- Hyperinsulin euglycaemic clamp
|